Integral Health Asset Management LLC Has $9.19 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Integral Health Asset Management LLC cut its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 9.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 100,000 shares of the medical device company's stock after selling 10,000 shares during the period. Integral Health Asset Management LLC owned 0.05% of Cooper Companies worth $9,193,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the company. Jefferies Financial Group Inc. increased its stake in shares of Cooper Companies by 138.9% during the 4th quarter. Jefferies Financial Group Inc. now owns 48,514 shares of the medical device company's stock worth $4,460,000 after purchasing an additional 28,204 shares during the last quarter. Gotham Asset Management LLC bought a new stake in shares of Cooper Companies during the 4th quarter worth about $530,000. Graham Capital Management L.P. boosted its holdings in shares of Cooper Companies by 6.0% during the 4th quarter. Graham Capital Management L.P. now owns 24,797 shares of the medical device company's stock worth $2,280,000 after buying an additional 1,409 shares during the period. Ethic Inc. boosted its holdings in shares of Cooper Companies by 6.5% during the 4th quarter. Ethic Inc. now owns 8,524 shares of the medical device company's stock worth $784,000 after buying an additional 517 shares during the period. Finally, D. E. Shaw & Co. Inc. boosted its holdings in shares of Cooper Companies by 41.7% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 344,643 shares of the medical device company's stock worth $31,683,000 after buying an additional 101,494 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

COO has been the subject of several research analyst reports. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Stifel Nicolaus reduced their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. JPMorgan Chase & Co. reduced their target price on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Friday, March 7th. Robert W. Baird cut their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. Finally, Piper Sandler reissued an "overweight" rating and issued a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, Cooper Companies has a consensus rating of "Moderate Buy" and an average target price of $110.25.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $82.27 on Monday. The company has a 50 day moving average of $80.54 and a 200-day moving average of $90.81. The Cooper Companies, Inc. has a 1-year low of $69.81 and a 1-year high of $112.38. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company has a market cap of $16.45 billion, a PE ratio of 42.19, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.